Max Reinhardt's most recent trade in Orthofix Medical Inc was a trade of 1,643 Common Stock done at an average price of $11.6 . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Orthofix Medical Inc | Max Reinhardt | President, Global Spine | Sale of securities on an exchange or to another person at price $ 11.64 per share. | 11 Jun 2025 | 1,643 | 27,481 (0%) | 0% | 11.6 | 19,125 | Common Stock |
| Orthofix Medical Inc | Max Reinhardt | President, Global Spine | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 34,924 | 34,924 | - | - | Employee Stock Option (Right to Buy) | |
| Orthofix Medical Inc | Max Reinhardt | President, Global Spine | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Mar 2025 | 14,723 | 29,124 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Sale of securities on an exchange or to another person at price $ 37.87 per share. | 06 Jun 2023 | 1,099 | 29,225 (0%) | 0% | 37.9 | 41,614 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Sale of securities on an exchange or to another person at price $ 38.99 per share. | 06 Jun 2023 | 1,054 | 30,324 (0%) | 0% | 39.0 | 41,097 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Sale of securities on an exchange or to another person at price $ 58.00 per share. | 07 Oct 2022 | 1,380 | 31,378 (0%) | 0% | 58 | 80,040 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 19,900 | 19,900 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2022 | 7,950 | 32,250 (0%) | 0% | 0 | Common Stock | |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Sale of securities on an exchange or to another person at price $ 61.37 per share. | 06 Jun 2022 | 2,817 | 26,833 (0%) | 0% | 61.4 | 172,891 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Sale of securities on an exchange or to another person at price $ 62.00 per share. | 06 Jun 2022 | 2,433 | 24,400 (0%) | 0% | 62 | 150,846 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.54 per share. | 21 Apr 2022 | 12,500 | 39,474 (0%) | 0% | 42.5 | 531,750 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Apr 2022 | 12,500 | 100,000 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Sale of securities on an exchange or to another person at price $ 73.25 per share. | 21 Apr 2022 | 9,824 | 29,650 (0%) | 0% | 73.3 | 719,647 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.54 per share. | 18 Apr 2022 | 12,500 | 30,000 (0%) | 0% | 42.5 | 531,750 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Apr 2022 | 12,500 | 112,500 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Apr 2022 | 12,500 | 125,000 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Apr 2022 | 12,500 | 137,500 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.54 per share. | 18 Apr 2022 | 12,500 | 36,738 (0%) | 0% | 42.5 | 531,750 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.54 per share. | 18 Apr 2022 | 12,500 | 33,559 (0%) | 0% | 42.5 | 531,750 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Sale of securities on an exchange or to another person at price $ 73.99 per share. | 18 Apr 2022 | 9,764 | 26,974 (0%) | 0% | 74.0 | 722,438 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Sale of securities on an exchange or to another person at price $ 72.25 per share. | 18 Apr 2022 | 9,321 | 24,238 (0%) | 0% | 72.2 | 673,442 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Sale of securities on an exchange or to another person at price $ 73.55 per share. | 18 Apr 2022 | 8,941 | 21,059 (0%) | 0% | 73.6 | 657,611 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Sale of securities on an exchange or to another person at price $ 59.76 per share. | 02 Jul 2021 | 421 | 17,500 (0%) | 0% | 59.8 | 25,159 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Sale of securities on an exchange or to another person at price $ 60.50 per share. | 04 Jun 2021 | 2,278 | 10,500 (0%) | 0% | 60.5 | 137,819 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President, Rest of World | Sale of securities on an exchange or to another person at price $ 61.04 per share. | 04 Jun 2021 | 1,222 | 12,778 (0%) | 0% | 61.0 | 74,587 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President | Sale of securities on an exchange or to another person at price $ 60.81 per share. | 06 Jan 2021 | 110 | 14,000 (0%) | 0% | 60.8 | 6,689 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Nov 2020 | 25,000 | 150,000 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Max Reinhardt | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.54 per share. | 13 Nov 2020 | 25,000 | 39,000 (0%) | 0% | 42.5 | 1,063,500 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President | Sale of securities on an exchange or to another person at price $ 63.51 per share. | 13 Nov 2020 | 21,000 | 14,000 (0%) | 0% | 63.5 | 1,333,710 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President | Sale of securities on an exchange or to another person at price $ 62.67 per share. | 13 Nov 2020 | 4,000 | 35,000 (0%) | 0% | 62.7 | 250,680 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 17 Sep 2020 | 25,000 | 175,000 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Max Reinhardt | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 42.54 per share. | 17 Sep 2020 | 25,000 | 39,000 (0%) | 0% | 42.5 | 1,063,500 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President | Sale of securities on an exchange or to another person at price $ 59.75 per share. | 17 Sep 2020 | 22,532 | 16,888 (0%) | 0% | 59.8 | 1,346,287 | Common Stock |
| Pacira BioSciences Inc | Max Reinhardt | President | Sale of securities on an exchange or to another person at price $ 60.26 per share. | 17 Sep 2020 | 2,888 | 14,000 (0%) | 0% | 60.3 | 174,031 | Common Stock |